Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
esmo 2024
May 5, 2024, 07:48 |
Blog
Timothée Olivier: The regulatory failure of sotorasib in lung!
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals shared a thread on X:…
May 5, 2024, 06:56 |
Blog
Khalid El Bairi: Men can be of high value to support women in their career
Khalid El Bairi, International Executive Council at NCODA shared a post on LinkedIn: "Men can be…
May 4, 2024, 10:53 |
Dialogues
OncoInfluencers: Dialogue with Tony Mok, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In this episode, we…
May 4, 2024, 07:02 |
Blog
Myriam Chalabi: Looking forward to reading all the exciting lower GI abstracts!
Myriam Chalabi shared a post by ESMO on X, adding: "May 7th. ESMO24 deadline! Looking…
May 2, 2024, 14:25 |
Insight
Fabrice Andre: A nice seminar around Precision Medicine
Vivek Subbiah shared a post by Fabrice Andre, Head of Research Division at Gustave Roussy…
May 1, 2024, 01:25 |
Blog
Florian Lordick: The 7th Hellenic Conference of Oncology
Florian Lordick, Professor of Medicine and Director of the University Cancer Center Leipzig, shared on…
Apr 28, 2024, 16:53 |
Blog
Paolo Tarantino: Unmissable editorial on the current status and next steps for studying and treating brain metastases in breast oncology
Paolo Tarantino shared a post by ESMO Open, on X: "Unmissable editorial on the current status…
Apr 28, 2024, 12:38 |
Insight
Piotr Wysocki: Combined treatment (TKI+ICI) does not benefit favorable-risk mRCC patients
Piotr Wysocki recently shared on LinkedIn: "For several years, combined therapy based on the administration of…
Apr 25, 2024, 00:51 |
Insight
New Paper Alert! Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma Authors: T. Powles,…
Apr 21, 2024, 11:35 |
Insight
Samuel Kareff: Our pan-tumor analysis on the not-so-elusive HRAS mutation in solid tumors
Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…
29
30
31
32
33
All:
338
Posts:
301 - 310
Highlights on the U.S. - India Cancer Moonshot Dialogue
The Nobel Prize: "Without him my kids wouldn’t be here" - cancer survivor Sharon Belvin
The plight of cancer patients in war-torn regions highlight the urgent need for our collective support - UICC
Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Facebook
RSS Feed
Twitter
Linkedin
Youtube